

![]()



HER2 ( ErbB2 ) Antibodies Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report


The HER2 (ErbB2) antibodies market is experiencing robust growth, driven by increasing breast cancer prevalence and advancements in targeted therapies. The market was valued at approximately $XX billion in 2023 and is projected to expand significantly, reflecting rising demand for personalized medicine and innovative treatment options in oncology.
Request Sample Report

◍ Bio-Techne (Novus Biologicals, LLC)
◍ Thermo Fisher Scientific
◍ BioVision, Inc.,
◍ Cell Signaling Technology (CST)
◍ Atlas Antibodies
◍ Proteintech Group, Inc

The HER2 antibodies market features key players like Genentech, Novartis, and Pfizer, providing therapeutic solutions for cancers. Companies like Bio-Techne and Thermo Fisher offer diagnostic and research tools. Their innovations and partnerships enhance market growth, driving advancements in treatments and diagnostics, and improving patient outcomes globally. Revenue figures are not included.
◍ Genentech Inc. (F. Hoffmann-La Roche Ltd.)
◍ Novartis AG
◍ Abnova Corporation
◍ Pfizer, Inc.
◍ InvivoGen
◍ Celltrion, Inc.
◍ Biocon Limited
Request Sample Report


Hospitals
Clinics
◍ Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Request Sample Report



Request Sample Report
$ X Billion USD












